Kelly Mccann in Santa Monica, California

Home California Santa Monica

Kelly Mccann has Hematology/oncology as her primary medical specialty. Their primary office is: 2020 Santa Monica Blvd in Santa Monica, California.

They're a part of the: The Regents Of The University Of California medical group which has around 1,169 members. You can call their office at 310-458-2381 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Stanford University School Of Medicine and graduated in 2011 (around 13 years of experience). They are listed as doing telehealth appointments.

Kelly E Mccann Office Phone and Directions

Kelly Mccann
The Regents Of The University Of California
2020 Santa Monica Blvd
Santa Monica, California 90404
310-458-2381

Patient Ratings
Please rate your experience with Kelly Mccann below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 310-458-2381

Enter a starting address:

Healthcare Info for Kelly Mccann

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Stanford University School Of Medicine
Graduation Year: 2011
The Primary Medical Specialty for Kelly Mccann is listed as: Hematology/oncology
Approximate Years of Experience: 13
PAC (PECOS ID)#: 5991959272
NPI #: 1942599915
NPI Created On: 03/30/2011
NPI Last Updated Listed as: 08/22/2019
Primary Taxonomy Code: 207R00000X
License Number:
A131605
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, more than 30 minutes
Injection, diphenhydramine hcl, up to 50 mg
Infusion, normal saline solution, 250 cc

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $900

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 818581587

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $1,575

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 818624801

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $900

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 818647181

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813066083

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Payments Total: $1,375

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 834085693

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: NERLYNX

Open Associated Drug #1: 70437-240-18

Payments Total: $32

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834087659

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: NERLYNX

Open Associated Drug #1: 70437-240-18

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834091801

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: NERLYNX

Open Associated Drug #1: 70437-240-18

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2782759;EPRINTS;10087234

Record ID:: 845876335

Being Disputed:: No

Product Related: Yes

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2777128;CONCUR;10087234

Record ID:: 848237905

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONC

Name of Drug #1: Trodelvy

Open Associated Drug #1: 55135-132-01

Payments Total: $69

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 836346925

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: Enhertu

Open Associated Drug #1: 65597-406-01